Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
12.77
+0.01 (0.08%)
At close: Jul 17, 2026, 4:00 PM EDT
12.75
-0.02 (-0.16%)
After-hours: Jul 17, 2026, 7:58 PM EDT
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $754.9 million as of July 17, 2026. Its market cap has increased by 12.05% in one year.
Market Cap
754.90M
Enterprise Value
555.43M
1-Year Change
12.05%
Ranking
Category
Stock Price
$12.77
ChartMarket Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $754.90M, an increase of 447.82%. That is a compound annual growth rate of 16.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 754.90M | 49.66% |
| Dec 31, 2025 | 504.40M | 13.30% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
| Apr 16, 2015 | 137.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 788.08M |
| Design Therapeutics | 785.08M |
| Aura Biosciences | 770.99M |
| Bright Minds Biosciences | 755.06M |
| Rigel Pharmaceuticals | 750.07M |
| Candel Therapeutics | 745.89M |
| Monopar Therapeutics | 744.37M |
| Neurogene | 743.47M |